Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial
塞来昔布联合新辅助化疗治疗乳腺癌可能会因 COX-2 表达和 ER 状态不同而导致疗效恶化：REMAGUS02 试验的探索性分析
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.18.00636
Anne-Sophie Hamy, Sandrine Tury, Xiaofei Wang, Junheng Gao, Jean-Yves Pierga, Sylvie Giacchetti, Etienne Brain, Barbara Pistilli, Michel Marty, Marc Espié, Gabriel Benchimol, Enora Laas, Marick Laé, Bernard Asselain, Brice Aouchiche, Martin Edelman, Fabien Reyal
